login
login

Europe Daily Bulletin No. 7952

26 April 2001
Contents Publication in full By article 52 / 57
ECONOMIC INTERPENETRATION / (eu) chemicals

The Dutch-Swedish chemical and pharmaceutical group AKZO NOBEL acquired, through its subsidiary DIOSYNTH (ingredients for pharmaceutical products; turnover of EUR 380 million in 2000), the American CBSI - COVANCE BIOTECHNOLOGY SERVICES for a total of EUR 210 million. Specialised in the development and production of bio-pharmaceutical substances, CBSI is, this year, meant to record a turnover of USD 110 million.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION